Copyright © 2025 InvestDailyPro. All Rights Reserved.
Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared...
C29 Metals (C29:AU) has announced Multiple New Multi-Commodity Targets Download the PDF here. This post appeared first on investingnews.com
Here’s a quick recap of the crypto landscape for Friday (May 9) as of 9:00 p.m. UTC. Get the latest...
This week proved pivotal for the tech and energy sectors as market dynamics and the regulatory landscape shifted. Apple (NASDAQ:AAPL)...
Exchange-traded funds (ETFs) are one of the fastest-growing investment vehicles, and as uranium’s role in the energy transition grows, investors...
Legendary investor Warren Buffett is stepping down as CEO of Berkshire Hathaway (NYSE:BRK.A,NYSE:BRK.B) after six decades at the helm —...
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario...
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
Here’s a quick recap of the crypto landscape for Wednesday (May 7) as of 9:00 p.m. UTC. Get the latest...
Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company specializing in...
Copyright © 2025 InvestDailyPro. All Rights Reserved.
Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.